“Security researchers have identified potential cybersecurity vulnerabilities related to these insulin pumps,” the company’s notification said. “The insulin pumps are not being recalled and are not required to be returned. The company said it has provided its customers and their doctors with security precautions when using their insulin pump. The CDSCO said the alert applies to MiniMed Paradigm (MMT-715 MMT-712, and MMT-722) and MiniMed Paradigm Veo (MMT-754) insulin pumps. The company said the following models “are vulnerable” to this potential issue: MiniMed Paradigm 508, MiniMed Paradigm 511, MiniMed Paradigm 512/712, MiniMed Paradigm 712E, MiniMed Paradigm 515/715, and MiniMed Paradigm 522/722 with all software versions, and MiniMed Paradigm 523/723, MiniMed Paradigm 523K/723K with software versions 2.4A or lower, MiniMed Paradigm Veo 554/754 with software versions 2.6A or lower, and MiniMed Paradigm Veo 554CM/754CM with software versions 2.7A or lower.

Source: The Telegraph July 03, 2019 20:21 UTC